世界の子宮筋腫治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Uterine Fibroids Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5006 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、子宮筋腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（子宮内膜アブレーション、MRIガイド処理、子宮摘出術、筋腫核出術、子宮動脈塞栓術、ラジオ波焼灼術、その他）、用途別市場規模（病院、外科医院、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・子宮筋腫治療の市場動向 ・企業の競争状況、市場シェア ・子宮筋腫治療の種類別市場規模と予測2016-2027（子宮内膜アブレーション、MRIガイド処理、子宮摘出術、筋腫核出術、子宮動脈塞栓術、ラジオ波焼灼術、その他） ・子宮筋腫治療の用途別市場規模と予測2016-2027（病院、外科医院、その他） ・子宮筋腫治療の北米市場規模2016-2027（アメリカ、カナダ） ・子宮筋腫治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・子宮筋腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・子宮筋腫治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・子宮筋腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Blue Endo、Boston Scientific Corporation、Cooper Surgical、Acessa Health, Inc.、Karl Storz、LiNA Medical、Merit Medical Systems、Olympus Corporation） ・結論

Uterine fibroids are frequently found incidentally during a routine pelvic exam. There’s no single best approach to uterine fibroid treatment — many treatment options exist.

Market Analysis and Insights: Global Uterine Fibroids Treatment Market
The global Uterine Fibroids Treatment market size is projected to reach US$ 182 million by 2027, from US$ 154.8 million in 2020, at a CAGR of 3.4% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Uterine Fibroids Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Uterine Fibroids Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Uterine Fibroids Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Uterine Fibroids Treatment market.

Global Uterine Fibroids Treatment Scope and Market Size
Uterine Fibroids Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Uterine Fibroids Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Endometrial Ablation
MRI Guided Procedures
Hysterectomy
Myomectomy
Uterine Artery Embolization
Radiofrequency Ablation
Others

Segment by Application
Hospitals
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Blue Endo
Boston Scientific Corporation
Cooper Surgical
Acessa Health, Inc.
Karl Storz
LiNA Medical
Merit Medical Systems
Olympus Corporation

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Uterine Fibroids Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Endometrial Ablation
1.2.3 MRI Guided Procedures
1.2.4 Hysterectomy
1.2.5 Myomectomy
1.2.6 Uterine Artery Embolization
1.2.7 Radiofrequency Ablation
1.2.8 Others
1.3 Market by Application
1.3.1 Global Uterine Fibroids Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Uterine Fibroids Treatment Market Perspective (2016-2027)
2.2 Uterine Fibroids Treatment Growth Trends by Regions
2.2.1 Uterine Fibroids Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Uterine Fibroids Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Uterine Fibroids Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Uterine Fibroids Treatment Industry Dynamic
2.3.1 Uterine Fibroids Treatment Market Trends
2.3.2 Uterine Fibroids Treatment Market Drivers
2.3.3 Uterine Fibroids Treatment Market Challenges
2.3.4 Uterine Fibroids Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Uterine Fibroids Treatment Players by Revenue
3.1.1 Global Top Uterine Fibroids Treatment Players by Revenue (2016-2021)
3.1.2 Global Uterine Fibroids Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Uterine Fibroids Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Uterine Fibroids Treatment Revenue
3.4 Global Uterine Fibroids Treatment Market Concentration Ratio
3.4.1 Global Uterine Fibroids Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Uterine Fibroids Treatment Revenue in 2020
3.5 Uterine Fibroids Treatment Key Players Head office and Area Served
3.6 Key Players Uterine Fibroids Treatment Product Solution and Service
3.7 Date of Enter into Uterine Fibroids Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Uterine Fibroids Treatment Breakdown Data by Type
4.1 Global Uterine Fibroids Treatment Historic Market Size by Type (2016-2021)
4.2 Global Uterine Fibroids Treatment Forecasted Market Size by Type (2022-2027)

5 Uterine Fibroids Treatment Breakdown Data by Application
5.1 Global Uterine Fibroids Treatment Historic Market Size by Application (2016-2021)
5.2 Global Uterine Fibroids Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Uterine Fibroids Treatment Market Size (2016-2027)
6.2 North America Uterine Fibroids Treatment Market Size by Type
6.2.1 North America Uterine Fibroids Treatment Market Size by Type (2016-2021)
6.2.2 North America Uterine Fibroids Treatment Market Size by Type (2022-2027)
6.2.3 North America Uterine Fibroids Treatment Market Size by Type (2016-2027)
6.3 North America Uterine Fibroids Treatment Market Size by Application
6.3.1 North America Uterine Fibroids Treatment Market Size by Application (2016-2021)
6.3.2 North America Uterine Fibroids Treatment Market Size by Application (2022-2027)
6.3.3 North America Uterine Fibroids Treatment Market Size by Application (2016-2027)
6.4 North America Uterine Fibroids Treatment Market Size by Country
6.4.1 North America Uterine Fibroids Treatment Market Size by Country (2016-2021)
6.4.2 North America Uterine Fibroids Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Uterine Fibroids Treatment Market Size (2016-2027)
7.2 Europe Uterine Fibroids Treatment Market Size by Type
7.2.1 Europe Uterine Fibroids Treatment Market Size by Type (2016-2021)
7.2.2 Europe Uterine Fibroids Treatment Market Size by Type (2022-2027)
7.2.3 Europe Uterine Fibroids Treatment Market Size by Type (2016-2027)
7.3 Europe Uterine Fibroids Treatment Market Size by Application
7.3.1 Europe Uterine Fibroids Treatment Market Size by Application (2016-2021)
7.3.2 Europe Uterine Fibroids Treatment Market Size by Application (2022-2027)
7.3.3 Europe Uterine Fibroids Treatment Market Size by Application (2016-2027)
7.4 Europe Uterine Fibroids Treatment Market Size by Country
7.4.1 Europe Uterine Fibroids Treatment Market Size by Country (2016-2021)
7.4.2 Europe Uterine Fibroids Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Uterine Fibroids Treatment Market Size (2016-2027)
8.2 Asia-Pacific Uterine Fibroids Treatment Market Size by Type
8.2.1 Asia-Pacific Uterine Fibroids Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Uterine Fibroids Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Uterine Fibroids Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Uterine Fibroids Treatment Market Size by Application
8.3.1 Asia-Pacific Uterine Fibroids Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Uterine Fibroids Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Uterine Fibroids Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Uterine Fibroids Treatment Market Size by Region
8.4.1 Asia-Pacific Uterine Fibroids Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Uterine Fibroids Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Uterine Fibroids Treatment Market Size (2016-2027)
9.2 Latin America Uterine Fibroids Treatment Market Size by Type
9.2.1 Latin America Uterine Fibroids Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Uterine Fibroids Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Uterine Fibroids Treatment Market Size by Type (2016-2027)
9.3 Latin America Uterine Fibroids Treatment Market Size by Application
9.3.1 Latin America Uterine Fibroids Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Uterine Fibroids Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Uterine Fibroids Treatment Market Size by Application (2016-2027)
9.4 Latin America Uterine Fibroids Treatment Market Size by Country
9.4.1 Latin America Uterine Fibroids Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Uterine Fibroids Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Uterine Fibroids Treatment Market Size (2016-2027)
10.2 Middle East & Africa Uterine Fibroids Treatment Market Size by Type
10.2.1 Middle East & Africa Uterine Fibroids Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Uterine Fibroids Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Uterine Fibroids Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Uterine Fibroids Treatment Market Size by Application
10.3.1 Middle East & Africa Uterine Fibroids Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Uterine Fibroids Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Uterine Fibroids Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Uterine Fibroids Treatment Market Size by Country
10.4.1 Middle East & Africa Uterine Fibroids Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Uterine Fibroids Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Blue Endo
11.1.1 Blue Endo Company Details
11.1.2 Blue Endo Business Overview
11.1.3 Blue Endo Uterine Fibroids Treatment Introduction
11.1.4 Blue Endo Revenue in Uterine Fibroids Treatment Business (2016-2021)
11.1.5 Blue Endo Recent Development
11.2 Boston Scientific Corporation
11.2.1 Boston Scientific Corporation Company Details
11.2.2 Boston Scientific Corporation Business Overview
11.2.3 Boston Scientific Corporation Uterine Fibroids Treatment Introduction
11.2.4 Boston Scientific Corporation Revenue in Uterine Fibroids Treatment Business (2016-2021)
11.2.5 Boston Scientific Corporation Recent Development
11.3 Cooper Surgical
11.3.1 Cooper Surgical Company Details
11.3.2 Cooper Surgical Business Overview
11.3.3 Cooper Surgical Uterine Fibroids Treatment Introduction
11.3.4 Cooper Surgical Revenue in Uterine Fibroids Treatment Business (2016-2021)
11.3.5 Cooper Surgical Recent Development
11.4 Acessa Health, Inc.
11.4.1 Acessa Health, Inc. Company Details
11.4.2 Acessa Health, Inc. Business Overview
11.4.3 Acessa Health, Inc. Uterine Fibroids Treatment Introduction
11.4.4 Acessa Health, Inc. Revenue in Uterine Fibroids Treatment Business (2016-2021)
11.4.5 Acessa Health, Inc. Recent Development
11.5 Karl Storz
11.5.1 Karl Storz Company Details
11.5.2 Karl Storz Business Overview
11.5.3 Karl Storz Uterine Fibroids Treatment Introduction
11.5.4 Karl Storz Revenue in Uterine Fibroids Treatment Business (2016-2021)
11.5.5 Karl Storz Recent Development
11.6 LiNA Medical
11.6.1 LiNA Medical Company Details
11.6.2 LiNA Medical Business Overview
11.6.3 LiNA Medical Uterine Fibroids Treatment Introduction
11.6.4 LiNA Medical Revenue in Uterine Fibroids Treatment Business (2016-2021)
11.6.5 LiNA Medical Recent Development
11.7 Merit Medical Systems
11.7.1 Merit Medical Systems Company Details
11.7.2 Merit Medical Systems Business Overview
11.7.3 Merit Medical Systems Uterine Fibroids Treatment Introduction
11.7.4 Merit Medical Systems Revenue in Uterine Fibroids Treatment Business (2016-2021)
11.7.5 Merit Medical Systems Recent Development
11.8 Olympus Corporation
11.8.1 Olympus Corporation Company Details
11.8.2 Olympus Corporation Business Overview
11.8.3 Olympus Corporation Uterine Fibroids Treatment Introduction
11.8.4 Olympus Corporation Revenue in Uterine Fibroids Treatment Business (2016-2021)
11.8.5 Olympus Corporation Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Uterine Fibroids Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Endometrial Ablation
Table 3. Key Players of MRI Guided Procedures
Table 4. Key Players of Hysterectomy
Table 5. Key Players of Myomectomy
Table 6. Key Players of Uterine Artery Embolization
Table 7. Key Players of Radiofrequency Ablation
Table 8. Key Players of Others
Table 9. Global Uterine Fibroids Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Uterine Fibroids Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Uterine Fibroids Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Uterine Fibroids Treatment Market Share by Regions (2016-2021)
Table 13. Global Uterine Fibroids Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Uterine Fibroids Treatment Market Share by Regions (2022-2027)
Table 15. Uterine Fibroids Treatment Market Trends
Table 16. Uterine Fibroids Treatment Market Drivers
Table 17. Uterine Fibroids Treatment Market Challenges
Table 18. Uterine Fibroids Treatment Market Restraints
Table 19. Global Uterine Fibroids Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Uterine Fibroids Treatment Market Share by Players (2016-2021)
Table 21. Global Top Uterine Fibroids Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Uterine Fibroids Treatment as of 2020)
Table 22. Ranking of Global Top Uterine Fibroids Treatment Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Uterine Fibroids Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Uterine Fibroids Treatment Product Solution and Service
Table 26. Date of Enter into Uterine Fibroids Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Uterine Fibroids Treatment Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Uterine Fibroids Treatment Revenue Market Share by Type (2016-2021)
Table 30. Global Uterine Fibroids Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Uterine Fibroids Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Uterine Fibroids Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Uterine Fibroids Treatment Revenue Market Share by Application (2016-2021)
Table 34. Global Uterine Fibroids Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Uterine Fibroids Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Uterine Fibroids Treatment Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Uterine Fibroids Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Uterine Fibroids Treatment Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Uterine Fibroids Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Uterine Fibroids Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Uterine Fibroids Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Uterine Fibroids Treatment Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Uterine Fibroids Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Uterine Fibroids Treatment Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Uterine Fibroids Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Uterine Fibroids Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Uterine Fibroids Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Uterine Fibroids Treatment Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Uterine Fibroids Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Uterine Fibroids Treatment Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Uterine Fibroids Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Uterine Fibroids Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Uterine Fibroids Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Uterine Fibroids Treatment Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Uterine Fibroids Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Uterine Fibroids Treatment Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Uterine Fibroids Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Uterine Fibroids Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Uterine Fibroids Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Uterine Fibroids Treatment Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Uterine Fibroids Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Uterine Fibroids Treatment Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Uterine Fibroids Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Uterine Fibroids Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Uterine Fibroids Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 66. Blue Endo Company Details
Table 67. Blue Endo Business Overview
Table 68. Blue Endo Uterine Fibroids Treatment Product
Table 69. Blue Endo Revenue in Uterine Fibroids Treatment Business (2016-2021) & (US$ Million)
Table 70. Blue Endo Recent Development
Table 71. Boston Scientific Corporation Company Details
Table 72. Boston Scientific Corporation Business Overview
Table 73. Boston Scientific Corporation Uterine Fibroids Treatment Product
Table 74. Boston Scientific Corporation Revenue in Uterine Fibroids Treatment Business (2016-2021) & (US$ Million)
Table 75. Boston Scientific Corporation Recent Development
Table 76. Cooper Surgical Company Details
Table 77. Cooper Surgical Business Overview
Table 78. Cooper Surgical Uterine Fibroids Treatment Product
Table 79. Cooper Surgical Revenue in Uterine Fibroids Treatment Business (2016-2021) & (US$ Million)
Table 80. Cooper Surgical Recent Development
Table 81. Acessa Health, Inc. Company Details
Table 82. Acessa Health, Inc. Business Overview
Table 83. Acessa Health, Inc. Uterine Fibroids Treatment Product
Table 84. Acessa Health, Inc. Revenue in Uterine Fibroids Treatment Business (2016-2021) & (US$ Million)
Table 85. Acessa Health, Inc. Recent Development
Table 86. Karl Storz Company Details
Table 87. Karl Storz Business Overview
Table 88. Karl Storz Uterine Fibroids Treatment Product
Table 89. Karl Storz Revenue in Uterine Fibroids Treatment Business (2016-2021) & (US$ Million)
Table 90. Karl Storz Recent Development
Table 91. LiNA Medical Company Details
Table 92. LiNA Medical Business Overview
Table 93. LiNA Medical Uterine Fibroids Treatment Product
Table 94. LiNA Medical Revenue in Uterine Fibroids Treatment Business (2016-2021) & (US$ Million)
Table 95. LiNA Medical Recent Development
Table 96. Merit Medical Systems Company Details
Table 97. Merit Medical Systems Business Overview
Table 98. Merit Medical Systems Uterine Fibroids Treatment Product
Table 99. Merit Medical Systems Revenue in Uterine Fibroids Treatment Business (2016-2021) & (US$ Million)
Table 100. Merit Medical Systems Recent Development
Table 101. Olympus Corporation Company Details
Table 102. Olympus Corporation Business Overview
Table 103. Olympus Corporation Revenue in Uterine Fibroids Treatment Business (2016-2021) & (US$ Million)
Table 104. Olympus Corporation Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Uterine Fibroids Treatment Market Share by Type: 2020 VS 2027
Figure 2. Endometrial Ablation Features
Figure 3. MRI Guided Procedures Features
Figure 4. Hysterectomy Features
Figure 5. Myomectomy Features
Figure 6. Uterine Artery Embolization Features
Figure 7. Radiofrequency Ablation Features
Figure 8. Others Features
Figure 9. Global Uterine Fibroids Treatment Market Share by Application: 2020 VS 2027
Figure 10. Hospitals Case Studies
Figure 11. Ambulatory Surgical Centers Case Studies
Figure 12. Others Case Studies
Figure 13. Uterine Fibroids Treatment Report Years Considered
Figure 14. Global Uterine Fibroids Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Uterine Fibroids Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Uterine Fibroids Treatment Market Share by Regions: 2020 VS 2027
Figure 17. Global Uterine Fibroids Treatment Market Share by Regions (2022-2027)
Figure 18. Global Uterine Fibroids Treatment Market Share by Players in 2020
Figure 19. Global Top Uterine Fibroids Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Uterine Fibroids Treatment as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Uterine Fibroids Treatment Revenue in 2020
Figure 21. Global Uterine Fibroids Treatment Revenue Market Share by Type (2016-2021)
Figure 22. Global Uterine Fibroids Treatment Revenue Market Share by Type (2022-2027)
Figure 23. North America Uterine Fibroids Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Uterine Fibroids Treatment Market Share by Type (2016-2027)
Figure 25. North America Uterine Fibroids Treatment Market Share by Application (2016-2027)
Figure 26. North America Uterine Fibroids Treatment Market Share by Country (2016-2027)
Figure 27. United States Uterine Fibroids Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Uterine Fibroids Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Uterine Fibroids Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Uterine Fibroids Treatment Market Share by Type (2016-2027)
Figure 31. Europe Uterine Fibroids Treatment Market Share by Application (2016-2027)
Figure 32. Europe Uterine Fibroids Treatment Market Share by Country (2016-2027)
Figure 33. Germany Uterine Fibroids Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Uterine Fibroids Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Uterine Fibroids Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Uterine Fibroids Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Uterine Fibroids Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Uterine Fibroids Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Uterine Fibroids Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Uterine Fibroids Treatment Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Uterine Fibroids Treatment Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Uterine Fibroids Treatment Market Share by Region (2016-2027)
Figure 43. China Uterine Fibroids Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Uterine Fibroids Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Uterine Fibroids Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Uterine Fibroids Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Uterine Fibroids Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Uterine Fibroids Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Uterine Fibroids Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Uterine Fibroids Treatment Market Share by Type (2016-2027)
Figure 51. Latin America Uterine Fibroids Treatment Market Share by Application (2016-2027)
Figure 52. Latin America Uterine Fibroids Treatment Market Share by Country (2016-2027)
Figure 53. Mexico Uterine Fibroids Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Uterine Fibroids Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Uterine Fibroids Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Uterine Fibroids Treatment Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Uterine Fibroids Treatment Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Uterine Fibroids Treatment Market Share by Country (2016-2027)
Figure 59. Turkey Uterine Fibroids Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Uterine Fibroids Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Uterine Fibroids Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Blue Endo Revenue Growth Rate in Uterine Fibroids Treatment Business (2016-2021)
Figure 63. Boston Scientific Corporation Revenue Growth Rate in Uterine Fibroids Treatment Business (2016-2021)
Figure 64. Cooper Surgical Revenue Growth Rate in Uterine Fibroids Treatment Business (2016-2021)
Figure 65. Acessa Health, Inc. Revenue Growth Rate in Uterine Fibroids Treatment Business (2016-2021)
Figure 66. Karl Storz Revenue Growth Rate in Uterine Fibroids Treatment Business (2016-2021)
Figure 67. LiNA Medical Revenue Growth Rate in Uterine Fibroids Treatment Business (2016-2021)
Figure 68. Merit Medical Systems Revenue Growth Rate in Uterine Fibroids Treatment Business (2016-2021)
Figure 69. Olympus Corporation Revenue Growth Rate in Uterine Fibroids Treatment Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---